Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Classical hematology 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 18Venous Thromboembolism 16Venous Thrombosis 5Pulmonary Embolism 4Treatment of Venous Thromboembolism in Cancer Patients 3Thrombosis 3Multiple Myeloma 3Upper Extremity Deep Vein Thrombosis 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Leukemia 1Inflammation 1Immune System Diseases 1Hemorrhage 1Hematologic Neoplasms 1

Interventions

Dexamethasone 808Bortezomib 446Lenalidomide 430Cyclophosphamide 336Melphalan 250Calcium Dobesilate 236daratumumab 217pomalidomide 201carfilzomib 181fludarabine phosphate 131Thalidomide 121fludarabine 118Peripheral Blood Stem Cell Transplantation 117Filgrastim 111ixazomib 85Mycophenolic Acid 85Granulocyte Colony-Stimulating Factor 84Busulfan 83Whole-Body Irradiation 80Tacrolimus 75dexamethasone acetate 74Cyclosporine 67Prednisone 64dexamethasone 21-phosphate 63isatuximab 62elotuzumab 60auricularum 57Antilymphocyte Serum 55belantamab mafodotin 54Etoposide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Multiple Myeloma × Rivaroxaban × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT03428373 2024-02-29

RithMM

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2/3 Unknown
57 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡